. Non-significant anti-cancer effects of epithelial growth factor receptor (EGFR) inhibitors on J82 human bladder cancer cells and autophagy activation. 
. Non-significant anti-cancer effects of epithelial growth factor receptor (EGFR) inhibitors on J82 human bladder cancer cells and autophagy activation. (5μM) in J82 human bladder cancer cells by performing cell viability analysis under different treatment combinations (control, gefitinib, autophagy inhibitors and both agents). The autophagy inhibitors used in this study were 5 nM of bafilomycin A1 (BFA1), 10 μM of chloroquine (CQ) and 10 mM of 3-methyladenine (3-MA). Cell viability is shown as the mean percentage (%) of the control ± SEM (n = 3, ** p < 0.01, *** p < 0.001).
(B) (a) Western blot analysis to determine the knock-down efficiency and autophagy suppression by transfection of ATG12-siRNA (si_ATG12) (50 nM) for 48 h in J82 cells, combined with 5 μM of gefitinib treatment. Scramble siRNA (si_Con) (50 nM) was used as a negative control of si_ATG12. (b) Under the same treatment conditions of gefitinib (5 μM) and 50 nM of si_ATG12 for 48 h, the cell viability assay was performed and data are represented by the mean percentage of the control ± SEM (n = 3, * p < 0.05).
